Zenocutuzumab--zbco, marketed as BIZENGRI (R), received Breakthrough Therapy Designation from the FDA in October 2025 and was granted accelerated approval in December 2024 for adults with advanced ...

A new study reveals that cancer patients diagnosed during the early COVID-19 pandemic had worse short-term survival rates ...

As the management landscape of primary biliary cholangitis (PBC) changes, new second-line options offer effective ...

About a combination of chloroquine and hydroxychloroquine: It will probably be at least a year before we have a vaccine for ...

Tyler Stapp, COO of Pineville Community Health Center, advances patient access by modernizing rural healthcare facilities ...

U.S. goalkeeper Kasey Keller was in peak condition when he felt hip pain. He went to get an MRI of his hip and quickly ...

Emerging evidence suggests that the widely used diabetes drug metformin, when taken early in a Covid-19 infection, may ...

At-home STD tests and newly approved treatments are expanding options for screening, privacy and care as U.S. infection rates decline.

LIBERTY is part of the Company’s broader REVOLUTION clinical program designed to elaborate the profile of monoclonal antibody-mediated ...

Six years ago, the Director-General of the World Health Organization sounded the highest global alarm available under ...

To help answer common vaccine questions, we consulted Dr. Stanley Perlman, a professor at the University of Iowa’s Carver ...